Correlation Between Sartorius Stedim and ATEME SA

Can any of the company-specific risk be diversified away by investing in both Sartorius Stedim and ATEME SA at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Sartorius Stedim and ATEME SA into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Sartorius Stedim Biotech and ATEME SA, you can compare the effects of market volatilities on Sartorius Stedim and ATEME SA and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Sartorius Stedim with a short position of ATEME SA. Check out your portfolio center. Please also check ongoing floating volatility patterns of Sartorius Stedim and ATEME SA.

Diversification Opportunities for Sartorius Stedim and ATEME SA

-0.07

Correlation Coefficient

Sartorius Stedim  ATEME SA

Good diversification

The 3 months correlation between Sartorius and ATEME is -0.07. Overlapping area represents the amount of risk that can be diversified away by holding Sartorius Stedim Biotech and ATEME SA in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on ATEME SA and Sartorius Stedim is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Sartorius Stedim Biotech are associated (or correlated) with ATEME SA. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of ATEME SA has no effect on the direction of Sartorius Stedim i.e., Sartorius Stedim and ATEME SA go up and down completely randomly.

Pair Corralation between Sartorius Stedim and ATEME SA

Assuming the 90 days trading horizon Sartorius Stedim Biotech is expected to generate 0.97 times more return on investment than ATEME SA. However, Sartorius Stedim Biotech is 1.04 times less risky than ATEME SA. It trades about -0.02 of its potential returns per unit of risk. ATEME SA is currently generating about -0.02 per unit of risk. If you would invest  26,010  in Sartorius Stedim Biotech on October 4, 2024 and sell it today you would lose (7,500) from holding Sartorius Stedim Biotech or give up 28.84% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Insignificant
Accuracy	99.7%
Values	Daily Returns

Sartorius Stedim Biotech  vs.  ATEME SA

Sartorius Stedim Biotech

Risk-Adjusted Performance

1 of 100

Weak

Compared to the overall equity markets, risk-adjusted returns on investments in Sartorius Stedim Biotech are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. Despite somewhat strong primary indicators, Sartorius Stedim is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.

ATEME SA

Risk-Adjusted Performance

24 of 100

Solid

Compared to the overall equity markets, risk-adjusted returns on investments in ATEME SA are ranked lower than 24 (%) of all global equities and portfolios over the last 90 days. Even with relatively weak basic indicators, ATEME SA reported solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Sartorius Stedim and ATEME SA

The main advantage of trading using opposite Sartorius Stedim and ATEME SA positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Sartorius Stedim position performs unexpectedly, ATEME SA can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in ATEME SA will offset losses from the drop in ATEME SA's long position.

The idea behind Sartorius Stedim Biotech and ATEME SA pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Commodity Directory module to find actively traded commodities issued by global exchanges.